1. Home
  2. PTCT vs RDNT Comparison

PTCT vs RDNT Comparison

Compare PTCT & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$62.76

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo RadNet Inc.

RDNT

RadNet Inc.

HOLD

Current Price

$61.50

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
RDNT
Founded
1998
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.7B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
PTCT
RDNT
Price
$62.76
$61.50
Analyst Decision
Buy
Strong Buy
Analyst Count
17
5
Target Price
$79.41
$86.00
AVG Volume (30 Days)
1.0M
820.8K
Earning Date
05-12-2026
06-02-2026
Dividend Yield
N/A
N/A
EPS Growth
264.48
N/A
EPS
7.78
N/A
Revenue
$264,734,000.00
$1,616,630,000.00
Revenue This Year
N/A
$12.24
Revenue Next Year
$21.65
$9.52
P/E Ratio
$8.14
N/A
Revenue Growth
36.19
13.05
52 Week Low
$35.95
$45.00
52 Week High
$87.50
$85.84

Technical Indicators

Market Signals
Indicator
PTCT
RDNT
Relative Strength Index (RSI) 21.26 35.11
Support Level $57.74 $53.23
Resistance Level $63.19 $74.09
Average True Range (ATR) 2.77 3.35
MACD -0.57 -0.50
Stochastic Oscillator 8.82 0.87

Price Performance

Historical Comparison
PTCT
RDNT

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

Share on Social Networks: